Page 4 - Avalon Technologies News Today

The Association of Mutual Funds in India (AMFI) is set to release the results of its stock categorization review, with expected changes to the largecap, midcap, and smallcap categories. According to Nuvama Institutional Equities, seven stocks will be upgraded to the largecap category, including Punjab National Bank and Shriram Finance. Additionally, nine stocks are likely to be downgraded from smallcap to midcap, such as Punjab & Sind Bank and Bharat Dynamics. Nuvama also predicts the moveme...

Macquarie has maintained its outperform rating on IndusInd Bank with a target price of Rs 1510, as the bank aims to strengthen its balance sheet by making more contingent provisions and raise net interest margins from 4.2-4.3% to 4.4%. Macquarie has also downgraded Paytm to neutral with a target price of Rs 800 due to a sharp run-up in the share price but expects accounting profitability from the platform by FY26. Additionally, brokerage firms Spark and CLSA recommended a buy rating on EMS playe...

Cyient DLM has initiated its initial public offering for subscription, with a price band of INR250-265 ($3.36-$3.55) and a proposed market capitalisation of INR2,102 crore. The entire IPO comprises fresh equity shares worth up to INR592 crore. Analysts recommend subscribing to the issue for the long term, given attractive valuations, strong growth potential and the companys focus on the entire life cycle of a product. Cyient DLM is a printed circuit board assembly solutions specialist with long-...

The total amount raised through initial public offerings stood at Rs 52,116 crore in FY23, of which LIC alone was Rs 21,000 crore

Based on the OI percentage, 117 stocks were on the short-covering list. These included Tata Communications, Delta Corp, Power Finance Corporation, ICICI Lombard General Insurance Company, and Atul.

A granular way to track equity mutual funds action is to evaluate the portfolio shifts of large fund houses based on equity AUM.

The Rs 4,326 crore IPO, which was the largest so far this year, received a strong response, as the issue was subscribed 15.32 times.

Mankinds Rs 4326 crore initial public offering (IPO) ranks as Indias biggest so far in 2023 and the third-biggest ever and it is also the biggest among Indian pharma companies since Gland Pharma went public in 2020, , mankind pharma, initial public offering

Amid global market turmoil, no startup appears to be nearing an IPO launch and we are already twenty days into the second quarter of 2023

The March quarter earnings season has got off to a rocky start, with IT majors posting a sobering set of numbers amid the gathering clouds of recession in the West.